financetom
Forex World Market Business Cryptocurrency Commodities MAP
financetom
Business
financetom
/
Business
/
GSK's Kidney Disease Treatment Receives FDA Orphan Designation
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
GSK's Kidney Disease Treatment Receives FDA Orphan Designation
Aug 29, 2025 10:07 AM

12:46 PM EDT, 08/29/2025 (MT Newswires) -- GSK's (GSK) treatment of autosomal dominant polycystic kidney disease received orphan designation from the US Food and Drug Administration, the agency said Friday.

The designation is for a fully human monoclonal antibody that binds human pregnancy-related plasma protein A, the FDA said.

Price: 39.52, Change: +0.08, Percent Change: +0.19

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Stride Insider Sold Shares Worth $2,270,896, According to a Recent SEC Filing
Stride Insider Sold Shares Worth $2,270,896, According to a Recent SEC Filing
Aug 20, 2025
05:22 PM EDT, 08/20/2025 (MT Newswires) -- James Jeaho Rhyu, Director, CEO, on August 18, 2025, sold 13,961 shares in Stride (LRN) for $2,270,896. Following the Form 4 filing with the SEC, Rhyu has control over a total of 706,353 common shares of the company, with 706,353 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1157408/000141588925022493/xslF345X05/form4-08202025_090842.xml ...
 Coty Stock Tumbles As Q4 Earnings Fall Short Of Estimates
Coty Stock Tumbles As Q4 Earnings Fall Short Of Estimates
Aug 20, 2025
Shares of global beauty maker Coty Inc ( COTY ) are moving lower in extended trading on Wednesday after the company reported mixed results for the fourth quarter of fiscal 2025. Here’s a rundown of the report. Q4 Highlights: Coty ( COTY ) reported fiscal fourth-quarter revenue of $1.25 billion, beating estimates of $1.20 billion, according to Benzinga Pro. The...
 Mercury Systems Insider Sold Shares Worth $976,285, According to a Recent SEC Filing
Mercury Systems Insider Sold Shares Worth $976,285, According to a Recent SEC Filing
Aug 20, 2025
05:19 PM EDT, 08/20/2025 (MT Newswires) -- David E. Farnsworth, Executive Vice President, CFO, on August 18, 2025, sold 14,911 shares in Mercury Systems ( MRCY ) for $976,285. Following the Form 4 filing with the SEC, Farnsworth has control over a total of 162,618 common shares of the company, with 161,326 shares held directly and 1,292 controlled indirectly. SEC...
 Eton Pharmaceuticals Insider Sold Shares Worth $673,714, According to a Recent SEC Filing
Eton Pharmaceuticals Insider Sold Shares Worth $673,714, According to a Recent SEC Filing
Aug 20, 2025
05:18 PM EDT, 08/20/2025 (MT Newswires) -- James R. Gruber, Chief Financial Officer, on August 19, 2025, sold 41,713 shares in Eton Pharmaceuticals ( ETON ) for $673,714. Following the Form 4 filing with the SEC, Gruber has control over a total of 204,753 common shares of the company, with 204,753 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1710340/000143774925027464/xslF345X05/rdgdoc.xml ...
About
Terms and Conditions Privacy policy Cookie Settings Contact Us
Services
Login register
financetom Market Personal Finance Business Economy Cryptocurrency MAP
Links
zpostcode Recruit weather mreligion Yellowpages sport constellation shopping name game directory literature Word tour furnish Lottery tftnews lyrics News digital car dir Edu Finance
Copyright 2023-2026 - www.financetom.com All Rights Reserved